PAAINESD Score Calculator – VT Ablation Hemodynamic Risk
Hemodynamic Risk Assessment
Select the preprocedural and planned procedural characteristics that apply to the patient undergoing scar-related VT ablation.
About the PAAINESD Score
The PAAINESD score is a clinical risk stratification tool intended to identify patients with structural heart disease undergoing scar-related ventricular tachycardia (VT) ablation who may be at increased risk of periprocedural acute hemodynamic decompensation (AHD).
The original PAINESD score contains seven variables and ranges from 0 to 31. The PAAINESD version adds planned general anesthesia (+4 points), resulting in a maximum score of 35.
Variables and Points
| Variable | Criterion | Points |
|---|---|---|
| Pulmonary disease | COPD | 5 |
| Age | >60 years | 3 |
| General anesthesia | Planned general anesthesia | 4 |
| Ischemic cardiomyopathy | Present | 6 |
| NYHA class | III or IV | 6 |
| LVEF | <25% | 3 |
| VT storm | Present | 5 |
| Diabetes mellitus | Present | 3 |
Risk thresholds and interpretation
With general anesthesia included: a PAAINESD score ≥17 has been cited as identifying a particularly high-risk group. The consensus statement describes the high-risk threshold as approximately 15–17 depending on whether general anesthesia is included.
Without general anesthesia: in the original PAINESD development cohort, the reported tertiles were ≤8 points (1% AHD), 9–14 points (6% AHD), and ≥15 points (24% AHD). These are cohort-derived estimates and should not be assumed to represent contemporary individualized probabilities.
The calculator displays both totals to make the anesthesia component transparent. It does not convert the PAAINESD total into an absolute probability because a directly validated probability mapping for every score value is not established here.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.